Cox regression analysis indicated that FOXQ1 expression suggested good prognosis in bladder urothelial carcinoma, kidney renal papillary cell carcinoma, prostate adenocarcinoma, and uterine corpus endometrial carcinoma and poor prognosis in liver hepatocellular carcinoma, pancreatic adenocarcinoma, and skin cutaneous melanoma (Figure 3B). The gene discussed is FOXQ1; the disease is bladder transitional cell carcinoma.